MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),，我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù),。

Necrostatin-1

CAS No. : 4311-88-0

MCE 國際站：Necrostatin-1

產(chǎn)品活性：Necrostatin-1 (Nec-1) 是一種有效的能透過血腦屏障的壞死性凋亡 (necroptosis) 抑制劑，在 Jurkat 細(xì)胞中的 EC₅₀ 為 490 nM,。Necrostatin-1 抑制 RIP1 激酶 (EC₅₀=182 nM) ,。Necrostatin-1 (Nec-1) 也是一種 (IDO) 抑制劑。

研究領(lǐng)域：Apoptosis  |  Autophagy  |  Metabolic Enzyme/Protease

作用靶點(diǎn)：RIP kinase  |  Autophagy  |  Indoleamine 2,3-Dioxygenase (IDO)  |  Ferroptosis

In Vitro: Necrostatin-1 (Nec-1) efficiently inhibits the TNFα-induced necrotic death of L929 cells, which does not require exogenous caspase inhibitors.
Necrostatin-1 (Nec-1) prevents radiocontrast media (RCM)-induced dilation of peritubular capillaries, suggesting a novel role unrelated to cell death for the RIP1 kinase domain in the regulation of microvascular hemodynamics and pathophysiology of contrast-induced AKI (CIAKI).
Necrostatin-1 (Nec-1) (30 μM) increases the survival of cardiomyocyte progenitor cell (CMPCs) by inhibiting necrotic cell death.

In Vivo: Necrostatin-1 (Nec-1) induces tubular bilation and affects the kinetics of the dilation of peritubular capillaries after RCM application. Upon a single intraperitoneal application of a single dose of Necrostatin-1 (1.65 mg/kg body weight, i.p.) 15 minutes before RCM, the return to baseline levels is prevented within the observation period.

相關(guān)產(chǎn)品：Bioactive Compound Library Plus  |  Apoptosis Compound Library  |  Immunology/Inflammation Compound Library  |  Kinase Inhibitor Library  |  Metabolism/Protease Compound Library  |  NF-κB Signaling Compound Library  |  Anti-Cancer Compound Library  |  CNS-Penetrant Compound Library  |  Autophagy Compound Library  |  Small Molecule Immuno-Oncology Compound Library  |  Ferroptosis Compound Library  |  Human Metabolite Library  |  Heterocyclic Compound Library  |  Metabolic Enzyme Compound Library  |  Membrane Protein-targeted Compound Library  |  Cell Death Library  |  Serine/Threonine Kinase Inhibitor Library  |  Multi-Target Compound Library  |  Bioactive Compound Library Max  |  Protein Kinase Compound Library  |  Ferrostatin-1  |  Erastin  |  Cisplatin  |  Cycloheximide  |  RSL3  |  Acetylcysteine  |  ML385  |  Sorafenib  |  Rosiglitazone  |  SP600125  |  Liproxstatin-1  |  Curcumin  |  Simvastatin  |  Acetaminophen  |  L-Glutathione reduced  |  Hemin  |  Trolox  |  Roxadustat  |  NADPH tetrasodium salt  |  Lapatinib  |  Lovastatin  |  L-Glutamic acid  |  Sulfasalazine  |  GSK-872  |  TBHQ  |  Pifithrin-α hydrobromide  |  U-73122  |  BODIPY 581/591 C11  |  Pioglitazone  |  3-TYP

熱門產(chǎn)品線：重組蛋白  |  藥物篩選  |  天然產(chǎn)物  |  熒光染料  |  PROTAC  |  同位素標(biāo)記物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds

品牌介紹:
?   MCE (MedChemExpress) 擁有200 多種全球獨(dú)家化合物庫,，我們致力于為全球科研客戶提供前沿最全的高品質(zhì)小分子活性化合物,；
?   50,000 多種高選擇性抑制劑、激動(dòng)劑涉及各熱門信號通路及疾病領(lǐng)域,；
?   產(chǎn)品種類涵蓋各種重組蛋白,，多肽,，常用試劑盒 ，更有 PROTAC,、ADC 等特色產(chǎn)品,，廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項(xiàng)目,；
?   提供虛擬篩選,，離子通道篩選，代謝組學(xué)分析檢測分析,，藥物篩選等專業(yè)技術(shù)服務(wù),；
?   設(shè)有專業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控、驗(yàn)證體系,；
?   提供 LC/MS,、NMR、HPLC,、手性分析,、元素分析等各項(xiàng)質(zhì)檢報(bào)告，確保產(chǎn)品的高純度,、高品質(zhì),；
?   產(chǎn)品的生物活性多經(jīng)各國客戶實(shí)驗(yàn)驗(yàn)證；
?   Nature, Cell, Science 等多種頂級期刊及制藥專利收錄了MCE客戶的科研成果,；
?   專業(yè)團(tuán)隊(duì)跟蹤最新的制藥及生命科學(xué)研究進(jìn)展,，為您提供全球最新的活性化合物；
?   與世界各大制藥公司及知名科研機(jī)構(gòu)建立了長期的合作,。